=+LG 2 P12–5 Scenario analysis Novartis International AG, a global healthcare company based in Switzerland, is considering producing either a generic multivitamin or a specific blend of vitamins A, C, and D. Novartis expects both products to provide benefits over a 12-year period, and each has a required (initial) investment of CHf 520,000 (CHf stands for Swiss Franc). The company uses a 6.35% cost of capital. Management has constructed the following table of estimated annual cash inflows for pessimistic, most likely, and optimistic results: